Engineered Polymer Nanoplatforms for Targeted Tumor Cells and Controlled Release Cargos to Enhance Cancer Treatment

Zhenjie Wang1, Longguang Tang1, Qingchun Mu1

  • 1The People's Hospital of Gaozhou, Maoming, 525200, China.

Current Medicinal Chemistry
|February 26, 2021
PubMed

Insights

Polymeric nanoparticles offer advanced drug delivery for cancer theranostics. These nanomaterials show significant advantages over traditional options for effective cancer treatment and therapy.

Area of Science:

  • Biomedical Engineering
  • Materials Science
  • Oncology

Background:

  • Cancer remains a leading cause of death with limited effective treatments.
  • Nanomaterials show promise in biomedical applications, including cancer imaging and therapy.
  • Polymeric nanoparticles are particularly notable for their tunable properties and drug-carrying capacity.

Purpose of the Study:

  • To review the applications of polymeric nanoparticles in cancer theranostics.
  • To highlight their role as drug delivery systems for cancer treatment.
  • To provide an overview of synthesis, applications, and evaluation methods.

Main Methods:

  • Literature review focusing on polymeric nanoparticles in cancer research.
  • Analysis of synthesis strategies and surface modification techniques.
  • Examination of drug delivery mechanisms and therapeutic evaluations.

Main Results:

  • Polymeric nanoparticles exhibit superior biocompatibility and drug loading compared to traditional nanomaterials.
  • These nanoparticles facilitate targeted drug delivery, enhancing cancer treatment efficacy.
  • Advancements in synthesis and functionalization enable versatile applications in theranostics.

Conclusions:

  • Polymeric nanoparticles represent a promising platform for cancer theranostics.
  • Their unique properties offer significant potential for improved cancer drug delivery and therapy.
  • Further research into their evaluation is crucial for clinical translation.